Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AdaptHealth (AHCO) Equity Average (2018 - 2025)

Historic Equity Average for AdaptHealth (AHCO) over the last 8 years, with Q3 2025 value amounting to $1.6 billion.

  • AdaptHealth's Equity Average rose 670.03% to $1.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.6 billion, marking a year-over-year increase of 670.03%. This contributed to the annual value of $1.5 billion for FY2024, which is 1599.26% down from last year.
  • Per AdaptHealth's latest filing, its Equity Average stood at $1.6 billion for Q3 2025, which was up 670.03% from $1.6 billion recorded in Q2 2025.
  • AdaptHealth's Equity Average's 5-year high stood at $2.2 billion during Q2 2023, with a 5-year trough of $1.0 billion in Q1 2021.
  • For the 5-year period, AdaptHealth's Equity Average averaged around $1.8 billion, with its median value being $1.8 billion (2021).
  • In the last 5 years, AdaptHealth's Equity Average surged by 192779.73% in 2021 and then tumbled by 3207.97% in 2024.
  • Quarter analysis of 5 years shows AdaptHealth's Equity Average stood at $2.0 billion in 2021, then rose by 6.32% to $2.2 billion in 2022, then dropped by 25.74% to $1.6 billion in 2023, then decreased by 3.25% to $1.6 billion in 2024, then grew by 3.76% to $1.6 billion in 2025.
  • Its last three reported values are $1.6 billion in Q3 2025, $1.6 billion for Q2 2025, and $1.6 billion during Q1 2025.